The OCRF is proud to support the Gynaecological Cancer Transformation Initiative, led by ANZGOG
Ovarian Cancer Research Foundation (OCRF) reshared a post by on LinkedIn:
“The survival rates for gynaecological cancers have barely changed in decades, and ovarian cancer remains the most lethal of them. We know that the answers are there – they lie in more research and they lie in better understanding of women’s bodies, and women’s pain. To reveal them we need appropriate and proportionate investment.
The OCRF is proud to support the Gynaecological Cancer Transformation Initiative, led by Australia New Zealand Gynaecological Oncology Group (ANZGOG), and add our voice to the call for urgent funding that will save lives from gynaecological cancers – now, and for generations to come.”
Quoting Australia New Zealand Gynaecological Oncology Group (ANZGOG)‘s post:
“A once-in-a-generation opportunity to change the future for Australian women.
After months of collaboration, consultation and deep commitment, today, we’re sharing a national initiative that is designed to transform how gynaecological cancers are diagnosed, treated and managed across Australia.
The Gynaecological Cancer Transformation Initiative (GCTI) is the result of significant work led by ANZGOG, with collaborative partners the Ovarian Cancer Research Foundation (OCRF) and Ovarian Cancer Australia (OCA) and many others — including clinicians, researchers and women with lived experience.
Together, we’ve developed an evidence-based plan to deliver equitable access to world-class care and save more than 30,000 lives over the next decade.
We’re incredibly grateful to Australian Broadcasting Corporation (ABC) News for shining a light on this urgent issue — and the solution we’ve built together.
Read the full story.
Every day:
- 19 women are diagnosed with a gynaecological cancer.
- 6 women lose their lives (over 2,200 every year).
- 55% of all gynaecological cancer diagnosis are rare or less common, meaning limited treatment options.
This is a hidden health crisis for women with these cancers — but it doesn’t have to be.
If you would like to learn more and support the Gynaecological Cancer Transformation Initiative, please visit.
With the deepest thanks to all our collaborators, researchers, advocates and especially all the women who continue to share their stories and drive change.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023